{"id":11750,"date":"2015-09-09T06:00:09","date_gmt":"2015-09-09T04:00:09","guid":{"rendered":"https:\/\/www.johner-institut.de\/blog\/?p=11750"},"modified":"2025-04-23T18:21:05","modified_gmt":"2025-04-23T16:21:05","slug":"fda-maude","status":"publish","type":"post","link":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/","title":{"rendered":"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement"},"content":{"rendered":"<div class=\"blog-column\">Die <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/search.cfm\" target=\"_blank\" rel=\"noopener\">FDA MAUDE Datenbank<\/a> stellt\u00a0Informationen zur &#8222;Manufacturer and User Facility Device Experience&#8220; bereit. Sie entspricht damit etwa der <a href=\"https:\/\/www.johner-institut.de\/blog\/category\/iec-62304-medizinische-software\/\" target=\"_blank\" rel=\"noopener\">Datenbank, mit der das BfArM Meldungen von Hersteller zur Risiken<\/a> publiziert.<\/div>\n<div class=\"blog-column\">\n<table class=\"table-blog\">\n<tbody>\n<tr>\n<th class=\"table-blog-header\"><i class=\"fa fa-play\" style=\"color: red;\" aria-hidden=\"true\"> \u00a0<\/i>Inhalts\u00fcbersicht<\/th>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/www.johner-institut.de\/blog\/fda\/fda-maude\/#inhalt\">Inhalt der MAUDE Datenbank \u00bb<\/a><\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/www.johner-institut.de\/blog\/fda\/fda-maude\/#auswertung\">Neues Werkzeug zur Auswertung \u00bb<\/a><\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/www.johner-institut.de\/blog\/fda\/fda-maude\/#regulations\">Regulatorischer Hintergrund \u00bb<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"blog-clear\"><\/div>\n<p><!--more--><\/p>\n<h2 id=\"inhalt\">Inhalt der FDA MAUDE Datenbank<\/h2>\n<p>Die FDA MAUDE Datenbank enth\u00e4lt Informationen zu<\/p>\n<ul>\n<li>dem Problem<\/li>\n<li>der Produktklasse und Produkt-Code<\/li>\n<li>Der Auswirkung des Zwischenfalls (Tod, Verletzung, &#8230;) (&#8222;Event&#8220;)<\/li>\n<li>Hersteller<\/li>\n<li>Datum der Meldung<\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE.jpg\" data-rel=\"lightbox-image-0\" data-rl_title=\"\" data-rl_caption=\"\" title=\"\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-11753\" src=\"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE.jpg\" alt=\"Suchmaske der FDA MAUDE Datenbank\" width=\"599\" height=\"212\" srcset=\"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE.jpg 599w, https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE-300x106.jpg 300w\" sizes=\"auto, (max-width: 599px) 100vw, 599px\" \/><\/a><\/p>\n<h2 id=\"regulations\">Regulatorischer Hintergrund<\/h2>\n<h3>Pflicht zur Auswertung<\/h3>\n<p>Hersteller sind verpflichtet, ein ad\u00e4quates Risikomanagement zu betreiben. Das schlie\u00dft die \u00dcberwachung des Produkts im Markt, aber auch \u00e4hnlicher Produkte und Technologien mit ein. Nur so kann es Herstellern gelingen,<\/p>\n<ul>\n<li><a href=\"https:\/\/www.johner-institut.de\/blog\/iso-14971-risikomanagement\/gefaehrdung-und-gefaehrdungssitation\/\" target=\"_blank\" rel=\"noopener\">Gef\u00e4hrdungen<\/a> m\u00f6glichst vollst\u00e4ndig zu identifizieren,<\/li>\n<li>Wahrscheinlichkeiten von Sch\u00e4den und Problemen\u00a0sowie<\/li>\n<li><a href=\"https:\/\/www.johner-institut.de\/blog\/iso-14971-risikomanagement\/schweregrad-schaden-iso-14971\/\" target=\"_blank\" rel=\"noopener\">Schweregrade<\/a>\u00a0von Sch\u00e4den m\u00f6glichst korrekt abzusch\u00e4tzen.<\/li>\n<\/ul>\n<p>Die Datenbanken des BfArMs sowie die FDA MAUDE\u00a0z\u00e4hlen zu den Quellen, die Sie dabei immer\u00a0einbeziehen sollten &#8212; unabh\u00e4ngig davon, in welchem Rechtsraum Sie Ihre Produkte vermarketen.<\/p>\n<h3>Pflicht zur Meldung<\/h3>\n<p>Sowohl in den USA als auch in Europa m\u00fcssen sowohl Hersteller als auch Anwender Probleme und Zwischenf\u00e4lle melden. Die FDA schreibt hierzu:<\/p>\n<ul>\n<li><cite><strong>Manufacturers<\/strong> and importers must submit reports when they become aware of information that reasonably suggests that one of their marketed devices may have caused or contributed to a death or serious injury or has malfunctioned and the malfunction of the device or a similar device that they market would be likely to cause or contribute to a death or serious injury if the malfunction were to recur. Manufacturers must send reports of such deaths, serious injuries and malfunctions to the FDA.<\/cite><\/li>\n<li><cite><strong>Importers<\/strong> must send reports of deaths and serious injuries to the FDA and the manufacturer, and reports of malfunctions to the manufacturer.<\/cite><\/li>\n<li><cite><strong>Device user facilities<\/strong> include hospitals, outpatient diagnostic or treatment facilities, nursing homes and ambulatory surgical facilities. Device user facilities must submit reports when they become aware of information that reasonably suggests that a device may have caused or contributed to a death or serious injury of a patient in their facility. Death reports must be sent to the FDA and the manufacturer, if known. Serious injury reports must be sent to the manufacturer or to the FDA, if the manufacturer is not known.<\/cite><\/li>\n<\/ul>\n<p>\u00c4nderungshistorie:<\/p>\n<ul>\n<li>2023-12-06: Verweis auf Maude-Analyzer des Johner Instituts entfernt<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Die FDA MAUDE Datenbank stellt\u00a0Informationen zur &#8222;Manufacturer and User Facility Device Experience&#8220; bereit. Sie entspricht damit etwa der Datenbank, mit der das BfArM Meldungen von Hersteller zur Risiken publiziert. \u00a0Inhalts\u00fcbersicht Inhalt der MAUDE Datenbank \u00bb Neues Werkzeug zur Auswertung \u00bb Regulatorischer Hintergrund \u00bb<\/p>\n","protected":false},"author":74,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":true,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1108],"tags":[1188],"ppma_author":[1213],"class_list":["post-11750","post","type-post","status-publish","format-standard","hentry","category-regulatory-affairs","tag-fda","category-1108","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement<\/title>\n<meta name=\"description\" content=\"Die FDA MAUDE Datenbank umfasst Meldungen zur &quot;Manufacturer and User Facility Device Experience&quot;. Sie ist im Rahmen des Risikomanagements zu ber\u00fccksichtigen\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement\" \/>\n<meta property=\"og:description\" content=\"Die FDA MAUDE Datenbank umfasst Meldungen zur &quot;Manufacturer and User Facility Device Experience&quot;. Sie ist im Rahmen des Risikomanagements zu ber\u00fccksichtigen\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/\" \/>\n<meta property=\"og:site_name\" content=\"Regulatorisches Wissen f\u00fcr Medizinprodukte\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/JohnerInstitut\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-09T04:00:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-23T16:21:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"599\" \/>\n\t<meta property=\"og:image:height\" content=\"212\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Christian Rosenzweig\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Christian Rosenzweig\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/\"},\"author\":{\"name\":\"Christian Rosenzweig\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/#\\\/schema\\\/person\\\/a1bfe9a403a4dd4f8aed197335feb568\"},\"headline\":\"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement\",\"datePublished\":\"2015-09-09T04:00:09+00:00\",\"dateModified\":\"2025-04-23T16:21:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/\"},\"wordCount\":393,\"commentCount\":2,\"publisher\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/09\\\/FDA-MAUDE.jpg\",\"keywords\":[\"FDA - Medizinprodukte in den USA\"],\"articleSection\":[\"Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/\",\"url\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/\",\"name\":\"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/09\\\/FDA-MAUDE.jpg\",\"datePublished\":\"2015-09-09T04:00:09+00:00\",\"dateModified\":\"2025-04-23T16:21:05+00:00\",\"description\":\"Die FDA MAUDE Datenbank umfasst Meldungen zur \\\"Manufacturer and User Facility Device Experience\\\". Sie ist im Rahmen des Risikomanagements zu ber\u00fccksichtigen\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/09\\\/FDA-MAUDE.jpg\",\"contentUrl\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/09\\\/FDA-MAUDE.jpg\",\"width\":599,\"height\":212,\"caption\":\"Suchmaske der FDA MAUDE Datenbank\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/regulatory-affairs\\\/fda-maude\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Blog\",\"item\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte\",\"item\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/category\\\/regulatory-affairs\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/\",\"name\":\"Regulatorisches Wissen f\u00fcr Medizinprodukte\",\"description\":\"Fachartikel zur Entwicklung und Zulassung von Medizinprodukten und weiteren regulatorischen Themen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/#organization\",\"name\":\"Johner Institut GmbH\",\"url\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/07\\\/Johner-Institut.png\",\"contentUrl\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/07\\\/Johner-Institut.png\",\"width\":1213,\"height\":286,\"caption\":\"Johner Institut GmbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/JohnerInstitut\\\/\",\"https:\\\/\\\/x.com\\\/christianjohner\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/JohnerInstitut\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/#\\\/schema\\\/person\\\/a1bfe9a403a4dd4f8aed197335feb568\",\"name\":\"Christian Rosenzweig\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Christian_Rosenzweig_300x300.png608f3c25642fdf010fd6a50508840c4c\",\"url\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Christian_Rosenzweig_300x300.png\",\"contentUrl\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Christian_Rosenzweig_300x300.png\",\"caption\":\"Christian Rosenzweig\"},\"description\":\"Christian Rosenzweig ist seit mehr als 20 Jahren im regulierten Medizinprodukteumfeld t\u00e4tig und ein absoluter Enthusiast in diesem Bereich. Er ist Mitglied des Normengremiums f\u00fcr Software und vernetzte Medizinprodukte, Experte f\u00fcr aktive Medizinprodukte, Risikomanagement und IT-Security, Leiter des Bereichs Risikomanagement und IT-Security am Johner Institut, Dozent f\u00fcr diese Themenbereiche bei Seminaren des Johner Instituts, sowie in dessen Studieng\u00e4nge. Operative Beratungsarbeit in Kundenprojekten gibt ihm die M\u00f6glichkeit, den Transfer zwischen Theorie und Praxis im Alltag anzuwenden.\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/christian-rosenzweig-150810134\\\/\"],\"url\":\"https:\\\/\\\/www.johner-institut.de\\\/blog\\\/author\\\/christianrosenzweig\\\/\"}]}<\/script>\n<meta name=\"copyright\" content=\"Johner Institut GmbH\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement","description":"Die FDA MAUDE Datenbank umfasst Meldungen zur \"Manufacturer and User Facility Device Experience\". Sie ist im Rahmen des Risikomanagements zu ber\u00fccksichtigen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/","og_locale":"de_DE","og_type":"article","og_title":"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement","og_description":"Die FDA MAUDE Datenbank umfasst Meldungen zur \"Manufacturer and User Facility Device Experience\". Sie ist im Rahmen des Risikomanagements zu ber\u00fccksichtigen","og_url":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/","og_site_name":"Regulatorisches Wissen f\u00fcr Medizinprodukte","article_publisher":"https:\/\/www.facebook.com\/JohnerInstitut\/","article_published_time":"2015-09-09T04:00:09+00:00","article_modified_time":"2025-04-23T16:21:05+00:00","og_image":[{"width":599,"height":212,"url":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE.jpg","type":"image\/jpeg"}],"author":"Christian Rosenzweig","twitter_misc":{"Verfasst von":"Christian Rosenzweig","Gesch\u00e4tzte Lesezeit":"3\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/#article","isPartOf":{"@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/"},"author":{"name":"Christian Rosenzweig","@id":"https:\/\/www.johner-institut.de\/blog\/#\/schema\/person\/a1bfe9a403a4dd4f8aed197335feb568"},"headline":"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement","datePublished":"2015-09-09T04:00:09+00:00","dateModified":"2025-04-23T16:21:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/"},"wordCount":393,"commentCount":2,"publisher":{"@id":"https:\/\/www.johner-institut.de\/blog\/#organization"},"image":{"@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/#primaryimage"},"thumbnailUrl":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE.jpg","keywords":["FDA - Medizinprodukte in den USA"],"articleSection":["Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/","url":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/","name":"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement","isPartOf":{"@id":"https:\/\/www.johner-institut.de\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/#primaryimage"},"image":{"@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/#primaryimage"},"thumbnailUrl":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE.jpg","datePublished":"2015-09-09T04:00:09+00:00","dateModified":"2025-04-23T16:21:05+00:00","description":"Die FDA MAUDE Datenbank umfasst Meldungen zur \"Manufacturer and User Facility Device Experience\". Sie ist im Rahmen des Risikomanagements zu ber\u00fccksichtigen","breadcrumb":{"@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/#primaryimage","url":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE.jpg","contentUrl":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/09\/FDA-MAUDE.jpg","width":599,"height":212,"caption":"Suchmaske der FDA MAUDE Datenbank"},{"@type":"BreadcrumbList","@id":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-maude\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Blog","item":"https:\/\/www.johner-institut.de\/blog\/"},{"@type":"ListItem","position":2,"name":"Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte","item":"https:\/\/www.johner-institut.de\/blog\/category\/regulatory-affairs\/"},{"@type":"ListItem","position":3,"name":"FDA MAUDE Datenbank: Input f\u00fcrs Risikomanagement"}]},{"@type":"WebSite","@id":"https:\/\/www.johner-institut.de\/blog\/#website","url":"https:\/\/www.johner-institut.de\/blog\/","name":"Regulatorisches Wissen f\u00fcr Medizinprodukte","description":"Fachartikel zur Entwicklung und Zulassung von Medizinprodukten und weiteren regulatorischen Themen","publisher":{"@id":"https:\/\/www.johner-institut.de\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.johner-institut.de\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.johner-institut.de\/blog\/#organization","name":"Johner Institut GmbH","url":"https:\/\/www.johner-institut.de\/blog\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.johner-institut.de\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/07\/Johner-Institut.png","contentUrl":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2015\/07\/Johner-Institut.png","width":1213,"height":286,"caption":"Johner Institut GmbH"},"image":{"@id":"https:\/\/www.johner-institut.de\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/JohnerInstitut\/","https:\/\/x.com\/christianjohner","https:\/\/www.youtube.com\/user\/JohnerInstitut"]},{"@type":"Person","@id":"https:\/\/www.johner-institut.de\/blog\/#\/schema\/person\/a1bfe9a403a4dd4f8aed197335feb568","name":"Christian Rosenzweig","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2024\/05\/Christian_Rosenzweig_300x300.png608f3c25642fdf010fd6a50508840c4c","url":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2024\/05\/Christian_Rosenzweig_300x300.png","contentUrl":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2024\/05\/Christian_Rosenzweig_300x300.png","caption":"Christian Rosenzweig"},"description":"Christian Rosenzweig ist seit mehr als 20 Jahren im regulierten Medizinprodukteumfeld t\u00e4tig und ein absoluter Enthusiast in diesem Bereich. Er ist Mitglied des Normengremiums f\u00fcr Software und vernetzte Medizinprodukte, Experte f\u00fcr aktive Medizinprodukte, Risikomanagement und IT-Security, Leiter des Bereichs Risikomanagement und IT-Security am Johner Institut, Dozent f\u00fcr diese Themenbereiche bei Seminaren des Johner Instituts, sowie in dessen Studieng\u00e4nge. Operative Beratungsarbeit in Kundenprojekten gibt ihm die M\u00f6glichkeit, den Transfer zwischen Theorie und Praxis im Alltag anzuwenden.","sameAs":["https:\/\/www.linkedin.com\/in\/christian-rosenzweig-150810134\/"],"url":"https:\/\/www.johner-institut.de\/blog\/author\/christianrosenzweig\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack-related-posts":[{"id":1435961,"url":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/recognized-consensus-standards-der-fda\/","url_meta":{"origin":11750,"position":0},"title":"Recognized Consensus Standards der FDA","author":"Katharina Keutgen","date":"9. Oktober 2018","format":false,"excerpt":"Die FDA bieten Herstellern an, sogenannte recognized consensus standards\u00a0bei der Zulassung ihrer Produkte zu nutzen. Die US-Beh\u00f6rde hat zu diesen consensus standards ein \u201eGuidance\u201c Dokument ver\u00f6ffentlicht, das Ihnen dieser Artikel vorstellt. Er beschreibt zudem die Voraussetzungen f\u00fcr die Anwendung der \"Standards\" und die Vorteile f\u00fcr Hersteller, weist aber auch auf\u2026","rel":"","context":"In &quot;Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte&quot;","block_context":{"text":"Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte","link":"https:\/\/www.johner-institut.de\/blog\/category\/regulatory-affairs\/"},"img":{"alt_text":"Kapitelstruktur des FDA Guidance Documents zu den Consensus Standards","src":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2018\/10\/FDA-Guidance-Document-Consensus-Standards.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2018\/10\/FDA-Guidance-Document-Consensus-Standards.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2018\/10\/FDA-Guidance-Document-Consensus-Standards.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2018\/10\/FDA-Guidance-Document-Consensus-Standards.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2018\/10\/FDA-Guidance-Document-Consensus-Standards.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2018\/10\/FDA-Guidance-Document-Consensus-Standards.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":5381653,"url":"https:\/\/www.johner-institut.de\/blog\/iec-62366-usability\/fda-human-factors-engineering\/","url_meta":{"origin":11750,"position":1},"title":"FDA Human Factors Engineering: Anforderungen an die Gebrauchstauglichkeit von Medizinprodukten","author":"Prof. Dr. Christian Johner","date":"2. September 2025","format":false,"excerpt":"Die FDA stellt klare Anforderungen an das Human Factors Engineering (HFE) bzw. Usability Engineering von Medizinprodukten. Doch f\u00fcr welche Produkte gelten diese Anforderungen? Welche regulatorischen Dokumente m\u00fcssen Sie kennen? Und wie setzen Sie die FDA-Vorgaben an das Human Factors Engineering praktisch um? Dieser Artikel gibt Ihnen einen vollst\u00e4ndigen \u00dcberblick \u00fcber\u2026","rel":"","context":"In &quot;Usability &amp; IEC 62366-1&quot;","block_context":{"text":"Usability &amp; IEC 62366-1","link":"https:\/\/www.johner-institut.de\/blog\/category\/iec-62366-usability\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/02\/FDA-Human-Factors-Submission-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/02\/FDA-Human-Factors-Submission-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/02\/FDA-Human-Factors-Submission-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/02\/FDA-Human-Factors-Submission-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/02\/FDA-Human-Factors-Submission-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/02\/FDA-Human-Factors-Submission-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":5376542,"url":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/predicate-device-substantial-equivalence\/","url_meta":{"origin":11750,"position":2},"title":"Predicate Device &#038; Substantial Equivalence","author":"Katharina Keutgen","date":"24. Oktober 2023","format":false,"excerpt":"Der Begriff 'Predicate Device' f\u00e4llt meist im Kontext von 510(k)-Zulassungen der FDA. Allerdings definiert die FDA diesen Begriff nicht. Sie legt hingegen fest, was 'Substantial Equivalence' ist. Klingt kompliziert? Der Nachweis der \u00c4quivalenz ist keinesfalls nur im Kontext der FDA relevant. Deshalb verschafft dieser Artikel Klarheit \u2013 gerade, aber nicht\u2026","rel":"","context":"In &quot;Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte&quot;","block_context":{"text":"Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte","link":"https:\/\/www.johner-institut.de\/blog\/category\/regulatory-affairs\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/10\/Predicate-Device-Substantial-Equivalence.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/10\/Predicate-Device-Substantial-Equivalence.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/10\/Predicate-Device-Substantial-Equivalence.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2023\/10\/Predicate-Device-Substantial-Equivalence.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":5378630,"url":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fda-registration\/","url_meta":{"origin":11750,"position":3},"title":"FDA Registration: Alle Jahre wieder!","author":"Christopher Seib","date":"14. Mai 2024","format":false,"excerpt":"Eine \"FDA Registration\" ist eine gesetzlich vorgeschriebene Eintragung von \"Establishments\" (wie Medizinprodukteherstellern) in eine FDA-Datenbank. Die FDA Registration darf nicht mit der UDI-Registrierung in der GUDID-Datenbank oder gar einer FDA-Zulassung verwechselt werden. Dieser Artikel beantwortet die wichtigsten Fragen und hilft, die h\u00e4ufigsten Fehler bei der FDA Registration zu vermeiden. 1.\u2026","rel":"","context":"In &quot;Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte&quot;","block_context":{"text":"Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte","link":"https:\/\/www.johner-institut.de\/blog\/category\/regulatory-affairs\/"},"img":{"alt_text":"Symbolbild, das die Rollen zeigt, die bei einer FDA-Registration zu unterscheiden sind","src":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2024\/05\/FDA-Registration-Roles-KI.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2024\/05\/FDA-Registration-Roles-KI.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2024\/05\/FDA-Registration-Roles-KI.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2024\/05\/FDA-Registration-Roles-KI.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":11244,"url":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/medizinprodukte-sicherheitsbeauftragter\/","url_meta":{"origin":11750,"position":4},"title":"Medizinprodukte Sicherheitsbeauftragter \u2013 Aufgaben und Voraussetzungen","author":"Margarita Rozhdestvenskaya","date":"14. Juli 2015","format":false,"excerpt":"Medizinprodukte-Sicherheitsbeauftragter: Diese Rolle wird im Medizinproduktegesetz gefordert, das jedoch seit Mai 2021 nur noch f\u00fcr Hersteller von IvD-Produkten gilt, jedoch nicht mehr f\u00fcr Hersteller von Medizinprodukten. Der Sicherheitsbeauftragte war eine \u201edeutsche Erfindung\u201c, die sich nicht direkt aus den europ\u00e4ischen Richtlinien wie der Medizinprodukterichtlinie ableiten lie\u00df. Vorsicht! Die nun g\u00fcltige Medizinprodukteverordnung\u2026","rel":"","context":"In &quot;Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte&quot;","block_context":{"text":"Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte","link":"https:\/\/www.johner-institut.de\/blog\/category\/regulatory-affairs\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":4772283,"url":"https:\/\/www.johner-institut.de\/blog\/regulatory-affairs\/fehler-bei-premarket-notification-510ks-vermeiden\/","url_meta":{"origin":11750,"position":5},"title":"510(k)-Verfahren: Die f\u00fcnf h\u00e4ufigsten Fehler bei der Premarket Notification vermeiden","author":"Margret Seidenfaden","date":"29. M\u00e4rz 2022","format":false,"excerpt":"510(k)-Verfahren, auch \u201cPremarket Notification\u201d genannt, geh\u00f6ren zu den g\u00e4ngigsten Verfahren, nach denen in den USA Medizinprodukte zugelassen werden. Das Konzept basiert darauf, die \u00c4quivalenz mit einem Vergleichsprodukt nachzuweisen. Doch dabei passieren schnell die immer gleichen Fehler, an denen die gesamte 510(k)-Zulassung scheitern kann. Das muss nicht sein! Erfahren Sie in\u2026","rel":"","context":"In &quot;Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte&quot;","block_context":{"text":"Regulatory Affairs: Regulatorische Anforderungen an Medizinprodukte","link":"https:\/\/www.johner-institut.de\/blog\/category\/regulatory-affairs\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2022\/03\/haeufige-fehler-bei-510k-thumbnail.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2022\/03\/haeufige-fehler-bei-510k-thumbnail.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2022\/03\/haeufige-fehler-bei-510k-thumbnail.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2022\/03\/haeufige-fehler-bei-510k-thumbnail.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2022\/03\/haeufige-fehler-bei-510k-thumbnail.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.johner-institut.de\/blog\/wp-content\/uploads\/2022\/03\/haeufige-fehler-bei-510k-thumbnail.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_shortlink":"https:\/\/wp.me\/pavawf-33w","jetpack_sharing_enabled":true,"authors":[{"term_id":1213,"user_id":74,"is_guest":0,"slug":"christianrosenzweig","display_name":"Christian Rosenzweig","avatar_url":{"url":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2024\/05\/Christian_Rosenzweig_300x300.png","url2x":"https:\/\/www.johner-institut.de\/blog\/wp-content\/uploads\/2024\/05\/Christian_Rosenzweig_300x300.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":"","9":""}],"_links":{"self":[{"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/posts\/11750","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/users\/74"}],"replies":[{"embeddable":true,"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/comments?post=11750"}],"version-history":[{"count":5,"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/posts\/11750\/revisions"}],"predecessor-version":[{"id":5377473,"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/posts\/11750\/revisions\/5377473"}],"wp:attachment":[{"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/media?parent=11750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/categories?post=11750"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/tags?post=11750"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.johner-institut.de\/blog\/wp-json\/wp\/v2\/ppma_author?post=11750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}